Position in AMGN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$17,721,277
-$2,604,674 QoQ
Shares Held
50,366
-18.9% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.22%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $451,805,560 across 10 Drug Manufacturers - General names. AMGN ranks #8 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
127,233 | $117,025,096 | |
| 2 | JNJ |
Johnson & Johnson
|
397,877 | $97,257,053 | |
| 3 | ABBV |
AbbVie Inc.
|
283,811 | $61,726,054 | |
| 4 | AZN |
Astrazeneca PLC
|
236,302 | $46,603,480 | |
| 5 | MRK |
Merck & Co., Inc.
|
364,485 | $43,843,900 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
222,601 | $31,023,901 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
332,662 | $20,175,950 | |
| 8 | AMGN |
Amgen Inc
This page
|
50,366 | $17,721,277 |
All Filings in AMGN
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $17,721,277 | 50,366 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $20,325,951 | 62,100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $13,319,840 | 47,200 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,238,836 | 11,600 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $17,914,125 | 57,500 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $10,529,856 | 40,400 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $9,021,880 | 28,000 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,779,045 | 44,100 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $14,813,072 | 52,100 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $6,749,408 | 30,400 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $9,863,400 | 40,800 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $12,344,080 | 47,000 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $12,599,860 | 55,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,697,790 | 56,300 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $15,882,882 | 70,600 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $15,013,090 | 70,600 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $17,671,875 | 72,500 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $14,231,932 | 57,200 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $13,565,280 | 59,000 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $9,124,344 | 35,900 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $8,349,444 | 35,400 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $7,926,743 | 39,100 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||